• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?体积转移系数(K(trans))与人类胶质瘤的组织学分级有关吗?
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2455-65.
2
Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?脑血容量和对比剂转移系数能否预测人类胶质瘤的预后?
AJNR Am J Neuroradiol. 2006 Apr;27(4):853-8.
3
Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.使用动态磁敏感对比增强灌注磁共振成像,比较从单室获得的灌注指标与药代动力学建模方法在不同胶质瘤分级中的应用。
AJNR Am J Neuroradiol. 2006 Oct;27(9):1975-82.
4
Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.脑胶质瘤的动态对比增强 MRI 肿瘤细胞增殖的定量评估。
Acad Radiol. 2019 Sep;26(9):1215-1221. doi: 10.1016/j.acra.2018.10.012. Epub 2018 Nov 8.
5
Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.基于体素的动态对比增强 MRI 直方图分析用于评估胶质瘤 IDH1 突变状态。
Eur J Radiol. 2020 Oct;131:109247. doi: 10.1016/j.ejrad.2020.109247. Epub 2020 Aug 27.
6
Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.胶质瘤患者肿瘤免疫组织化学与动态对比增强及DSC-MRI参数的相关性
AJNR Am J Neuroradiol. 2016 Dec;37(12):2217-2223. doi: 10.3174/ajnr.A4908. Epub 2016 Sep 1.
7
Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.动态对比增强和动态磁敏感对比灌注磁共振成像用于胶质瘤分级:使用热点和直方图分析对血管腔室和通透性参数的初步比较
Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22.
8
Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas.弥散敏感对比增强磁共振成像(DSC-MRI)与动态对比增强磁共振成像(DCE-MRI)在星形细胞瘤术前分级中诊断准确性的比较
AJNR Am J Neuroradiol. 2015 Nov;36(11):2017-22. doi: 10.3174/ajnr.A4398. Epub 2015 Jul 30.
9
Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.高级别胶质瘤中动态对比增强磁共振成像和动态磁敏感对比增强磁共振成像的体素转移常数与脑血容量估计值的逐像素比较
AJNR Am J Neuroradiol. 2015 May;36(5):871-6. doi: 10.3174/ajnr.A4231. Epub 2015 Jan 29.
10
Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.联合“T1增强脑灌注成像”与磁敏感加权定量成像鉴别II/III级与IV级胶质瘤
Neuroradiology. 2018 Jan;60(1):43-50. doi: 10.1007/s00234-017-1942-8. Epub 2017 Oct 31.

引用本文的文献

1
spatiotemporal mapping of proliferation activity in gliomas via water-exchange dynamic contrast-enhanced MRI.通过水交换动态对比增强磁共振成像对胶质瘤增殖活性进行时空映射
Theranostics. 2025 Mar 24;15(10):4693-4707. doi: 10.7150/thno.108479. eCollection 2025.
2
Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma.影像学在高级别胶质瘤的诊断、预后及治疗反应预测中的作用
J Med Signals Sens. 2024 Mar 27;14:7. doi: 10.4103/jmss.jmss_30_22. eCollection 2024.
3
Diagnostic Utility of Integration of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MR Perfusion Employing Split Bolus Technique in Differentiating High-Grade Glioma.采用分剂量团注技术的动态对比增强与动态磁敏感对比磁共振灌注成像联合应用在鉴别高级别胶质瘤中的诊断价值
Indian J Radiol Imaging. 2024 Jan 17;34(3):382-389. doi: 10.1055/s-0043-1777742. eCollection 2024 Jul.
4
Advanced Imaging Techniques for Newly Diagnosed and Recurrent Gliomas.用于新诊断和复发性胶质瘤的先进成像技术
Front Neurosci. 2022 Feb 23;16:787755. doi: 10.3389/fnins.2022.787755. eCollection 2022.
5
Specific Preoperative Dynamic Contrast-Enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of Glioblastoma Tissue and Predict Recurrence.特定的术前动态对比增强磁共振成像半定量标志物可与胶质母细胞瘤组织特定区域的血管生成相关,并预测复发。
Cureus. 2021 Jun 8;13(6):e15528. doi: 10.7759/cureus.15528. eCollection 2021 Jun.
6
Use of Indicator Dilution Principle to Evaluate Accuracy of Arterial Input Function Measured With Low-Dose Ultrafast Prostate Dynamic Contrast-Enhanced MRI.使用指示剂稀释原理评估低剂量超快前列腺动态对比增强MRI测量的动脉输入函数的准确性。
Tomography. 2019 Jun;5(2):260-265. doi: 10.18383/j.tom.2019.00004.
7
Robust estimation of hemo-dynamic parameters in traditional DCE-MRI models.传统 DCE-MRI 模型中血液动力学参数的稳健估计。
PLoS One. 2019 Jan 3;14(1):e0209891. doi: 10.1371/journal.pone.0209891. eCollection 2019.
8
The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies.高级脑肿瘤成像在中枢神经系统恶性肿瘤患者治疗中的作用。
Curr Treat Options Oncol. 2018 Jun 21;19(8):40. doi: 10.1007/s11864-018-0558-5.
9
Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma-Foundations and Future.胶质母细胞瘤中的扩散加权/张量成像、功能磁共振成像和灌注加权成像——基础与未来
Front Neurol. 2018 Jan 22;8:660. doi: 10.3389/fneur.2017.00660. eCollection 2017.
10
Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.对比增强灌注 MRI 技术在脑胶质瘤中的临床应用:最新进展与当前挑战。
Contrast Media Mol Imaging. 2017 Mar 20;2017:7064120. doi: 10.1155/2017/7064120. eCollection 2017.

本文引用的文献

1
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.通过动态磁敏感对比增强灌注磁共振成像比较脑血容量和血管通透性与胶质瘤分级的关系。
AJNR Am J Neuroradiol. 2004 May;25(5):746-55.
2
Measuring blood volume and vascular transfer constant from dynamic, T(2)*-weighted contrast-enhanced MRI.通过动态T(2)*加权对比增强磁共振成像测量血容量和血管转运常数。
Magn Reson Med. 2004 May;51(5):961-8. doi: 10.1002/mrm.20049.
3
A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas.传统药代动力学模型与首过药代动力学模型在人类胶质瘤中获得的Ktrans测量值的比较。
J Magn Reson Imaging. 2004 May;19(5):527-36. doi: 10.1002/jmri.20045.
4
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].与传统对比增强磁共振成像相比,利用动态自旋回波磁共振磁化率成像进行胶质肿瘤分级及预后预测:少突胶质细胞瘤相对脑血容量升高的混杂效应[校正后]
AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21.
5
New hybrid technique for accurate and reproducible quantitation of dynamic contrast-enhanced MRI data.用于动态对比增强MRI数据准确且可重复定量分析的新型混合技术。
Magn Reson Med. 2003 Dec;50(6):1286-95. doi: 10.1002/mrm.10652.
6
Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.胶质瘤分级:与传统磁共振成像相比,灌注磁共振成像和质子磁共振波谱成像的敏感性、特异性及预测价值
AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98.
7
Dynamic susceptibility contrast MRI of gliomas.胶质瘤的动态磁敏感对比磁共振成像
Neuroimaging Clin N Am. 2002 Nov;12(4):501-23. doi: 10.1016/s1052-5149(02)00026-6.
8
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma.新诊断胶质瘤定量动态对比增强磁共振成像的可重复性
Br J Radiol. 2003 Mar;76(903):153-62. doi: 10.1259/bjr/70653746.
9
Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data.利用首过动态对比增强磁共振成像数据的迭代分析同时绘制胶质瘤中的血容量和内皮通透性表面积乘积图。
Br J Radiol. 2003 Jan;76(901):39-50. doi: 10.1259/bjr/31662734.
10
Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.利用相对脑血流量和体积评估脑胶质瘤的组织病理学分级:初步结果
AJR Am J Roentgenol. 2002 Sep;179(3):783-9. doi: 10.2214/ajr.179.3.1790783.

体积转移系数(K(trans))与人类胶质瘤的组织学分级有关吗?

Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?

作者信息

Patankar Tufail F, Haroon Hamied A, Mills Samantha J, Balériaux Danielle, Buckley David L, Parker Geoff J M, Jackson Alan

机构信息

Imaging Science and Biomedical Engineering, Faculty of Medicine, University of Manchester, Manchester, United Kingdom.

出版信息

AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2455-65.

PMID:16286385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7976173/
Abstract

PURPOSE

The purpose of this study was to examine the relationship between contrast transfer coefficient [K(trans)] and grade in gliomas.

MATERIAL AND METHODS

Median values of K(trans), CBV(T1), and of the 95th percentile (95%) of the distribution (K(trans) [95%] and CBV(T1) [95%]) were calculated in 39 patients with glioma. Group comparisons and post hoc pairwise comparisons were performed. The relationship between variables and grade used Spearman rho and canonical discriminant analysis. The separation of high- from low-grade tumors was separately assessed by using Mann-Whitney U tests and logistic regression. Receiver operator curve analysis was performed for high- and low-grade tumors and grade III and grade IV tumors.

RESULTS

There were significant differences between grades for all variables (P < .001). Pairwise comparisons demonstrated significant differences between grades II and III and II and IV for all variables except K(trans), which did not show significance in the grade II and III comparison, and between III and IV for CBV(T1) and CBV(T1) (95%; P < .01). All variables correlated with grade (P < .01). Discriminant analysis showed independent relation between both CBV(T1) and K(trans) (95%) and grade, and the canonical function produced a total correct classification of 74.4% of cases. Logistic regression analysis for low- versus high-grade tumors showed K(trans) (95%) and CBV(T1) to be independent factors (P < .01 and P < .05).

CONCLUSION

There are strong independent relationships between both CBV and K(trans) and histologic grade in gliomas. Both measurements show good discriminative power in distinguishing between low- and high-grade tumors with diagnostic sensitivity and specificity >90%.

摘要

目的

本研究旨在探讨对比剂转运系数[K(trans)]与胶质瘤分级之间的关系。

材料与方法

计算39例胶质瘤患者的K(trans)、CBV(T1)的中位数以及分布的第95百分位数(95%)(K(trans)[95%]和CBV(T1)[95%])。进行组间比较和事后两两比较。使用Spearman秩相关系数和典型判别分析来研究变量与分级之间的关系。通过Mann-Whitney U检验和逻辑回归分别评估高级别肿瘤与低级别肿瘤的区分情况。对高级别和低级别肿瘤以及III级和IV级肿瘤进行受试者操作特征曲线分析。

结果

所有变量在不同分级之间均存在显著差异(P <.001)。两两比较显示,除K(trans)在II级和III级比较中无显著差异外,所有变量在II级和III级、II级和IV级之间均存在显著差异,CBV(T1)和CBV(T1)(95%)在III级和IV级之间存在显著差异(P <.01)。所有变量均与分级相关(P <.01)。判别分析显示CBV(T1)和K(trans)(95%)与分级均存在独立关系,典型函数对病例的总正确分类率为74.4%。低级别与高级别肿瘤的逻辑回归分析显示K(trans)(95%)和CBV(T1)是独立因素(P <.01和P <.05)。

结论

CBV和K(trans)与胶质瘤的组织学分级均存在密切的独立关系。这两种测量方法在区分低级别和高级别肿瘤方面具有良好的鉴别能力,诊断敏感性和特异性均>90%。